The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI-Reference-Cited by-同舟云学术

The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI

Published:2019-04-12 Issue:7 Volume:44 Page:2474-2493
ISSN:2366-004X
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Rozenblum Laura^ORCID,Mokrane Fatima-Zohra,Yeh Randy,Sinigaglia Mathieu,Besson Florent,Seban Romain-David,Chougnet Cecile N,Revel-Mouroz Paul,Zhao Binsheng,Otal Philippe,Schwartz Lawrence H.,Dercle Laurent^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

http://link.springer.com/content/pdf/10.1007/s00261-019-01994-5.pdf

Reference117 articles.

1. Canellas R, Lo G, Bhowmik S, Ferrone C, Sahani D (2018) Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery. J Magn Reson Imaging 47 (2):425-432. https://doi.org/10.1002/jmri.25756

2. Smith JK, Ng SC, Hill JS, Simons JP, Arous EJ, Shah SA, Tseng JF, McDade TP (2010) Complications after pancreatectomy for neuroendocrine tumors: a national study. J Surg Res 163 (1):63-68. https://doi.org/10.1016/j.jss.2010.04.017

3. Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, Kos-Kudla B, Kwekkeboom D, Rindi G, Klöppel G, Reed N, Kianmanesh R, Jensen RT, Participants aoVCC (2016) ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology 103 (2):153-171. https://doi.org/10.1159/000443171

4. Vagefi PA, Razo O, Deshpande V, McGrath DJ, Lauwers GY, Thayer SP, Warshaw AL, Fernández-del Castillo C (2007) Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. Archives of Surgery 142 (4):347-354

5. Ellison TA, Wolfgang CL, Shi C, Cameron JL, Murakami P, Mun LJ, Singhi AD, Cornish TC, Olino K, Meriden Z, Choti M, Diaz LA, Pawlik TM, Schulick RD, Hruban RH, Edil BH (2014) A single institution’s 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram. Ann Surg 259 (2):204-212. https://doi.org/10.1097/sla.0b013e31828f3174

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG-PET/CT: a retrospective chart review;Nuclear Medicine Communications;2023-03-10

2. Pancreatic Neuroendocrine Tumors: Diagnosis, Management, and Intraoperative Techniques;Recent Innovations in Surgical Procedures of Pancreatic Neoplasms;2023

3. Multimodal Magnetic Resonance Imaging to Diagnose Knee Osteoarthritis under Artificial Intelligence;Computational Intelligence and Neuroscience;2022-06-23

4. Updated Trends in Imaging Practices for Pancreatic Neuroendocrine Tumors (PNETs): A Systematic Review and Meta-Analysis to Pave the Way for Standardization in the New Era of Big Data and Artificial Intelligence;Frontiers in Oncology;2021-07-14

5. Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors;Diagnostics;2020-12-07